Security key
552641102
MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (MAIA)
CUSIP: 552641102
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 60,521,183
- Total 13F shares
- 2,373,804
- Share change
- +89,449
- Total reported value
- $3,487,006
- Price per share
- $1.54
- Number of holders
- 19
- Value change
- +$129,244
- Number of buys
- 8
- Number of sells
- 7
Report period
Q3 2025
Institutions
19
Top holders
10
MAIA full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
MAIA Biotechnology, Inc. SEC filings
MAIA Biotechnology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 552641102
Recent filing periods:
Top shareholders of MAIA - MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FGMK Business Holdings, LLC |
13D/G
|
— |
10%
|
2,889,561
|
$6,068,078 | $0 | 14 Sep 2024 | |
| Sergei M. Gryaznov |
13D/G
|
— |
4.1%
|
1,140,115
|
$2,394,242 | $0 | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
1,140,769
|
$2,053,384 | — | 30 Jun 2025 | |
| Centric Wealth Management |
13F
|
Company |
0.95%
|
573,398
|
$871,565 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
222,183
|
$400,037 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.17%
|
103,265
|
$185,876 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
75,550
|
$135,990 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
39,032
|
$70,258 | — | 30 Jun 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
36,000
|
$64,800 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
28,783
|
$51,810 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.03%
|
16,165
|
$29,097 | — | 30 Jun 2025 | |
| Centerpoint Advisory Group |
13F
|
Company |
0.03%
|
15,730
|
$28,314 | — | 30 Jun 2025 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.02%
|
14,800
|
$27,380 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
8,334
|
$15,001 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
5,095
|
$9,171 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,120
|
$3,816 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,847
|
$3,325 | — | 30 Jun 2025 | |
| MAI Capital Management |
13F
|
Company |
0%
|
675
|
$1,215 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
231
|
$416 | — | 30 Jun 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
228
|
$404 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0%
|
100
|
$180 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
50
|
$90 | — | 30 Jun 2025 | |
| Mihail Obrocea |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
87,495
|
— | — | 31 May 2023 | |
| Joseph F. McGuire |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
69,075
|
— | — | 31 May 2023 | |
| Laurentiu Vlad |
3/4/5
|
Director |
—
class O/S missing
|
3,045
|
— | — | 30 Dec 2022 |
Institutional Holders of MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (MAIA) as of Q3 2025
As of 30 Sep 2025,
MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (MAIA) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,373,804 shares.
The largest 10 holders included
VANGUARD GROUP INC, Centric Wealth Management, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, BlackRock, Inc., STATE STREET CORP, NORTHERN TRUST CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Centerpoint Advisory Group, and WEALTH ENHANCEMENT ADVISORY SERVICES, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
20
Q3 2025 holders
19
Holder diff
-1
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.